• Who We Are
    • Management
    • Board of Directors
  • Our Science
    • Dismutase Mimetics
    • Reducing Oral Mucositis
    • Increasing Anti-Cancer Efficacy of Radiotherapy
    • COVID-19
    • Publications
  • Our Pipeline
    • Avasopasem (GC4419)
    • GC4711
    • Clinical Trials
  • Investors
  • Contact Us

Clinical Trials

For additional details on ongoing clinical trials, please visit www.clinicaltrials.gov.

Avasopasem

 

  • ROMAN: A Phase 3 Study to Investigate the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients with Head/Neck Cancer
  • EUSOM: Phase 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
  • AESOP: Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer
  • A Trial of GC4419 in Patients with Critical Illness Due to
    COVID-19

GC4711

 

  • GRECO-1: Phase 1/2 Study of SBRT With or Without GC4711 for NSCLC

© Copyright 2020 Galera Therapeutics
Website Design & Development Graphic Beans
Privacy Policy – Terms of Use – Compassionate Use Policy

LinkedIn